biotech investing BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
biotech investing BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
biotech investing BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+ in Breast and Prostate Cancer Models
biotech investing BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
biotech investing BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+ for Breast Cancer
biotech investing BriaCell's Bria-OTS+ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal
